Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Neurofilament-light Chain and Glial Fibrillary Acidic Proten (GFAP) Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

NCT03981003 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.

NCT NCT03981003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03981003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Neurofilament-light Chain and Glial Fibrillary Acidic Proten (GFAP) Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Phase
Observational
Overall status
Recruiting
Start date
May 22, 2019
Completion date
June 30, 2028
Enrollment
1,150 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis